🔎 Trials Near Me

Beranda › Kanker Hati (Karsinoma Hepatoseluler) › Massachusetts

Uji klinis Kanker Hati (Karsinoma Hepatoseluler) di Massachusetts

19 studi untuk Kanker Hati (Karsinoma Hepatoseluler) mencari peserta di lokasi di Massachusetts.

Kota di Massachusetts

Teks studi resmi (Bahasa Inggris)

Study of Zanzalintinib in Combination With Immuno-Oncology or Other Agents in Participants With Solid Tumors

  • Exelixis Clinical Site #7, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 1 Okt 2026 · NCT05176483

National Liver Cancer Screening Trial

  • Massachusetts General Hospital, Boston
Menerima pesertaFase 4
Usia 18 hingga 85 · Semua jenis kelamin · Diperbarui 25 Sep 2026 · NCT06084234

Safety and Preliminary Anti-Tumor Activity of TYRA-430 in Advanced Hepatocellular Carcinoma and Other Solid Tumors With Activating FGF/FGFR Pathway Aberrations

  • Mass General Cancer Center, Boston
Menerima pesertaFase 1
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT06915753

Visugromab, Nivolumab and Lenvatinib Compared to Double Placebo and Lenvatinib in Unresectable or Metastatic Hepatocellular Carcinoma Post Anti-PD-(L)1 Failure

  • Massachusetts General Hospital, Boston
Menerima pesertaFase 2
Usia 18 hingga 100 · Semua jenis kelamin · Diperbarui 23 Sep 2026 · NCT07219459

Real-world Evaluation of the HistoSonics Edison System for Treatment of Liver Tumors Across Multidisciplinary Users (BOOMBOX: Master Study)

  • Mass General Brigham, Boston
Menerima pesertaStudi observasional
Usia 22 ke atas · Semua jenis kelamin · Diperbarui 11 Sep 2026 · NCT06486454

Tegavivint for the Treatment of Recurrent or Refractory Solid Tumors, Including Lymphomas and Desmoid Tumors

  • Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 1/2
12 Months – 30 Years · Semua jenis kelamin · Diperbarui 25 Agu 2026 · NCT04851119

FOG-001 in Locally Advanced or Metastatic Solid Tumors

  • Massachusetts General Hospital, Boston
  • Dana Farber Cancer Institute, Boston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT05919264

Testing Immunotherapy With or Without Stereotactic Body Radiation Therapy in Patients With Advanced Liver Cancer, HELIO-RT Trial

  • Massachusetts General Hospital Cancer Center, Boston
Menerima pesertaFase 3
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 17 Agu 2026 · NCT07166406

First in Human Study to Evaluate AZD9793 in Participants With Advanced or Metastatic Solid Tumours

  • Research Site, Boston
Menerima pesertaFase 1/2
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 13 Agu 2026 · NCT06795022

A Study to Assess the Efficacy and Safety of FORE8394 in Participants With Cancer Harboring BRAF Alterations

  • Tufts Medical Center, Boston
  • Massachusetts General Hospital, Boston
  • Dana-Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 8 ke atas · Semua jenis kelamin · Diperbarui 27 Jul 2026 · NCT05503797

ET140203 T Cells in Pediatric Subjects With Hepatoblastoma, HCN-NOS, or Hepatocellular Carcinoma

  • Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Boston
Menerima pesertaFase 1/2
Usia 1 hingga 21 · Semua jenis kelamin · Diperbarui 6 Jul 2026 · NCT04634357

Preventing Liver Cancer Mortality Through Imaging With Ultrasound vs. MRI

  • VA Boston Healthcare System Jamaica Plain Campus, Jamaica Plain, MA, Boston
Menerima peserta
Usia 18 hingga 75 · Semua jenis kelamin · Diperbarui 17 Jun 2026 · NCT05486572

A Phase 1/1B Study of ST-01156, a Small Molecule RBM39 Degrader, in Patients With Advanced Solid Malignancies

  • Mass General Brigham Cancer Institute, Boston
  • Dana Farber Cancer Institute, Boston
Menerima pesertaFase 1
Usia 16 ke atas · Semua jenis kelamin · Diperbarui 2 Jun 2026 · NCT07197554

Computer Guided Microwave Liver Ablation

  • Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 hingga 90 · Semua jenis kelamin · Diperbarui 11 Mei 2026 · NCT07226869

Checkpoint Inhibition In Pediatric Hepatocellular Carcinoma

  • Children's Hospital Boston, Boston
  • Dana Farber Cancer Institute, Boston
Menerima pesertaFase 2
Usia 0 hingga 30 · Semua jenis kelamin · Diperbarui 24 Feb 2026 · NCT04134559

Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years

  • Massachussets General Hospital, Boston
Menerima pesertaFase 4
Usia 18 hingga 64 · Semua jenis kelamin · Diperbarui 22 Jan 2026 · NCT04373564

SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry

  • Massive Bio SYNERGY-AI site, Worcester
Menerima pesertaStudi observasional
Semua usia · Semua jenis kelamin · Diperbarui 28 Okt 2025 · NCT03452774

Value of [68Ga]Ga-PSMA-11 PET/MRI in the Assessment of Liver Cirrhosis

  • Athinoula A. Martinos Center for Biomedical Imaging, Massachusetts General Hospital, Harvard Medical School, Charlestown
Menerima pesertaStudi observasional
Usia 18 hingga 99 · Semua jenis kelamin · Diperbarui 26 Sep 2025 · NCT06265272

Psychoeducational Intervention for Patients With Hepatocellular Carcinoma

  • Massachusetts General Hospital, Boston
Menerima peserta
Usia 18 ke atas · Semua jenis kelamin · Diperbarui 29 Agu 2025 · NCT06541990

Dari ClinicalTrials.gov, data diambil 6 Okt 2026. Setiap studi menetapkan kriteria kelayakannya sendiri; tim studi yang menentukan siapa yang bisa bergabung.